Show simple item record

dc.creatorAnaya, Juan-Manuel 
dc.creatorBologna, C. 
dc.creatorJorgensen, C. 
dc.creatorAlric, R 
dc.creatorSany, J. 
dc.date.accessioned2020-08-19T14:42:11Z
dc.date.available2020-08-19T14:42:11Z
dc.date.created1995
dc.identifier.issnISSN: 0392-856X
dc.identifier.issnEISSN: 1593-098X
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/27434
dc.description.abstractTo determine the correlation between the pharmacokinetic (PK) parameters of methotrexate (MTX), clinical status and laboratory test results in rheumatoid arthritis (RA) patients.22 patients (4 M/18F, mean age: 50 +/- 12 years, mean duration of RA: 8.5 +/- 6.5 years, mean duration on MTX: 8 +/- 10 months) were included in a prospective study. The mean dose of MTX administered was 6 +/- 0.7 mg/m2 of body area/week. No patient received any nonsteroidal antiinflammatory drug (NSAID). Blood and urine samples were collected over 24 hours (9 blood samples). The MTX concentrations were assayed by fluorescence polarization immunoassay. Clinical parameters (Ritchie articular index, morning stiffness, joint pain count, joint swelling count), hematological, liver and renal function tests, and ESR were recorded. Correlations between the patients' PK parameters, laboratory tests and clinical status were carried out using Pearson's correlation coefficient test.A significant correlation was observed between the Ritchie articular index, morning stiffness and the area under the curve (p = 0.009 and p = 0.026, respectively). No correlation was found with the other parameters.These results suggest that when the patient's disease activity is higher, the AUC becomes more important, reflecting a greater body exposure to MTX.
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.relation.ispartofClinical and Experimental Rheumatology, ISSN: 0392-856X; EISSN: 1593-098X, Vol.13, No.4 (1995);pp. 465-470
dc.relation.urihttps://europepmc.org/article/med/7586778
dc.sourceClinical and Experimental Rheumatology
dc.titleCorrelation between methotrexate pharmacokinetic parameters, and clinical and biological status in rheumatoid arthritis patients
dc.typearticle
dc.publisherEurope PMC
dc.subject.keywordPharmacokinetic
dc.subject.keywordRheumatoid arthritis
dc.rights.accesRightsinfo:eu-repo/semantics/closedAccess
dc.type.spaArtículo
dc.rights.accesoBloqueado (Texto referencial)
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.title.TranslatedTitleCorrelación entre los parámetros farmacocinéticos del metotrexato y el estado clínico y biológico en pacientes con artritis reumatoide
dc.relation.citationEndPage470
dc.relation.citationIssueNo. 4
dc.relation.citationStartPage465
dc.relation.citationTitleClinical and Experimental Rheumatology
dc.relation.citationVolumeVol. 13
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record